| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 |
| filingDate |
2002-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7216aca8e3931c813094766a7499e7cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ab5a1d252f946768939c67c299c68d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_583b6dfc49fa255413d58ba4bfb2b166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f007e7748b874083f447cc67a5852586 |
| publicationDate |
2003-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003007970-A1 |
| titleOfInvention |
Lymphotactin uses |
| abstract |
This invention relates to the use of lymphotactin or lymphotactin antagonists for administration to an animal. The administration of these therapeutic entities will attract certain cell types, or can be blocked to prevent such attraction. It also provides means to protect stem cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2062592-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009065561-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009065561-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010310562-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10703817-B2 |
| priorityDate |
1996-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |